7210 Research and experimental development on natural sciences and engineering

Code: 
7210

Most active institutional investors by number of deals

Investor Profile Country Deals
Medtronic Inc Medical technology company specializing in implantable and invasive therapies. United States 31
Genentech Inc Discovery, development, commercialization and manufacturing of biotherapeutics by using human genetic information United States 11
Amgen Inc United States 9
Biogen Idec Inc United States 5
Genzyme Corp United States 5
Illumina Inc Developer, manufacturer, and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and function. United States 4
Quintiles Transnational Corp United States 4
Cephalon Inc Global biopharmaceutical company dedicated to discovering, developing and bringing to market medications. United States 3
Alexion Pharmaceuticals Inc Complement inhibition for cardiovascular and inflammatory diseases. United States 2
BioMarin Pharmaceutical Inc United States 2
Centocor Ortho Biotech Inc United States 2
Gen-Probe Inc United States 2
Millennium Pharmaceuticals Inc United States 2
Abcodia Ltd Clinical stage company engaged in the commercial development of novel, scientifically validated tests for the early detection of cancer. United Kingdom 1
ActivBiotics Inc A biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for the treatment of inflammatory diseases. United States 1
Antisoma PLC Investing company United Kingdom 1
Baxalta Inc 1
Cell Genesys Inc United States 1
Compound Therapeutics Inc Biotechnology company focused on protein-based drugs. United States 1
Corixa Corp United States 1

Pages

Selected companies

Company type: 
Britain’s national laboratory for fusion research.
Company type: 
Biotechnology company developing a new class of therapies for metabolic diseases and disorders.
Company type: 
Developer of engineered T regulatory cell therapies.
Company type: 
Biopharmaceutical company focused on bispecific antibodies.
Subscribe to RSS - 7210 Research and experimental development on natural sciences and engineering